- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07936513
Application of the Family-Centered Empowerment Model in an Intervention to Reduce Burden Among Primary Caregivers of Patients With Hip Fracture
Caring for a family member after a hip fracture can place physical, emotional, social, and financial demands on the main caregiver. This study evaluates whether a support program based on the Family-Centered Empowerment Model can reduce caregiver burden compared with usual care. The program helps caregivers understand care needs, develop practical skills, build confidence, and involve other family members in caregiving.
The study plans to include 80 adult family caregivers of patients with hip fracture at one hospital in China, with 40 caregivers in each group. Group assignment depends on the enrollment period rather than chance. Caregivers enrolled during the earlier period receive usual orthopedic care guidance and follow-up. Those enrolled during the later period receive the same usual care plus the empowerment program, including education, practical skills training, family discussions, and support after discharge.
Caregivers complete questionnaires near the patient's hospital admission, at discharge, and at 1 and 3 months after discharge. The main outcome is caregiver burden, meaning the strain and difficulties associated with providing care. Other outcomes include confidence in managing challenges, self-esteem, and caregiving-related quality of life. Patient complications and hospital readmissions are also recorded. The study will assess whether adding the empowerment program improves these outcomes.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Caring for a family member after a hip fracture can place physical, emotional, social, and financial demands on the main caregiver. This study evaluates whether a support program based on the Family-Centered Empowerment Model can reduce caregiver burden compared with usual care. The program helps caregivers understand care needs, develop practical skills, build confidence, and involve other family members in caregiving.
The study plans to include 80 adult family caregivers of patients with hip fracture at one hospital in China, with 40 caregivers in each group. Group assignment depends on the enrollment period rather than chance. Caregivers enrolled during the earlier period receive usual orthopedic care guidance and follow-up. Those enrolled during the later period receive the same usual care plus the empowerment program, including education, practical skills training, family discussions, and support after discharge.
Caregivers complete questionnaires near the patient's hospital admission, at discharge, and at 1 and 3 months after discharge. The main outcome is caregiver burden, meaning the strain and difficulties associated with providing care. Other outcomes include confidence in managing challenges, self-esteem, and caregiving-related quality of life. Patient complications and hospital readmissions are also recorded. The study will assess whether adding the empowerment program improves these outcomes.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Kangli zhu
- Numero di telefono: +8618258864804
- Email: 504053447@qq.com
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Inclusion Criteria:
- A family member serving as the primary caregiver of a patient with hip fracture aged 18 years or older.
- Has provided care for at least 3 months and provides care for at least 8 hours per day.
- Receives no remuneration for caregiving.
- Able to read and communicate.
- Willing to participate in the study and provide informed consent.
Exclusion Criteria:
- A history of psychiatric illness.
- Clinically diagnosed visual or hearing impairment that cannot be corrected with glasses, hearing aids, or other usual assistive devices and prevents the caregiver from reading study materials, participating in group discussions, or receiving study instructions. Age-related presbyopia or mild hearing loss that can be adequately corrected with assistive devices does not constitute an exclusion criterion.
Exclusion Criteria:
-
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Usual Orthopedic Care
Primary family caregivers of patients with hip fracture receive usual orthopedic care guidance and routine follow-up. This includes education on hip fracture and rehabilitation during hospital days 1-2, guidance on home caregiving before discharge, and weekly telephone or WeChat follow-up after discharge. Follow-up continues through 3 months after discharge. |
Usual orthopedic care guidance and follow-up are provided to primary family caregivers of patients with hip fracture from the patient's hospital admission through 3 months after discharge. The intervention includes education on hip fracture and basic rehabilitation during the first 1-2 days of hospitalization, guidance on home caregiving before discharge, and routine telephone or WeChat follow-up once weekly after discharge. Both the control and experimental groups receive this intervention. |
|
Sperimentale: Usual Care Plus Family-Centered Empowerment Model Intervention
Primary family caregivers receive usual orthopedic care guidance and follow-up plus a structured Family-Centered Empowerment Model intervention from admission through 3 months after discharge. The program includes: (1) within 24 hours of admission, a caregiving manual and a group discussion addressing perceived threat (about 30 minutes); (2) during hospital days 1-7, two individual hands-on caregiving skills and scenario-based simulation sessions to strengthen self-efficacy (about 40 minutes each); (3) from day 8 to discharge, two sessions involving family participation in care planning and sharing caregiving experiences to support self-esteem (about 30 minutes each); and (4) after discharge, five targeted follow-up contacts and two online caregiving experience-sharing sessions for process and outcome evaluation. |
Usual orthopedic care guidance and follow-up are provided to primary family caregivers of patients with hip fracture from the patient's hospital admission through 3 months after discharge. The intervention includes education on hip fracture and basic rehabilitation during the first 1-2 days of hospitalization, guidance on home caregiving before discharge, and routine telephone or WeChat follow-up once weekly after discharge. Both the control and experimental groups receive this intervention. Primary family caregivers of patients with hip fracture receive a four-stage Family-Centered Empowerment Model program in addition to usual care, from the patient's admission through 3 months after discharge: (1) perceived threat: a standardized caregiving manual and group discussion within 24 hours of admission (about 30 minutes); (2) self-efficacy: two individual hands-on caregiving skills and scenario-based simulation sessions during hospital days 1-7 (about 40 minutes each); (3) self-esteem: two sessions involving family participation in care planning and sharing caregiving experiences from day 8 to discharge (about 30 minutes each); and (4) process and outcome evaluation: five targeted follow-up contacts and two online caregiving experience-sharing sessions after discharge through 3 months. This program is provided only to the experimental group. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Caregiver Burden Measured by the Zarit Burden Interview (ZBI)
Lasso di tempo: aseline, Periprocedural, 1 month, 3 months
|
Caregiver burden is assessed using the 22-item Zarit Burden Interview (ZBI). Each item is scored from 0 to 4, and item scores are summed to produce a total score ranging from 0 to 88. Higher scores indicate greater caregiver burden. Total scores are assessed at baseline, hospital discharge, and 1 and 3 months after discharge. |
aseline, Periprocedural, 1 month, 3 months
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Ferite e lesioni
- Sintomi comportamentali
- Lesioni alla gamba
- Fratture, ossa
- Stress, Psicologico
- Fratture femorali
- Lesioni all'anca
- Comportamento
- Aderenza e conformità al trattamento
- Comportamento sanitario
- Conformità del paziente
- Accettazione dell'assistenza sanitaria da parte del paziente
- Interventi di aderenza
- Aderenza ai farmaci
- Onere del caregiver
- Fratture dell'anca
- Educazione alla salute
Altri numeri di identificazione dello studio
- KY-2026-113
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
De-identified individual participant data underlying the published study results, together with a data dictionary, will be made available to qualified researchers upon reasonable request. Data access will require a written research proposal describing the intended analyses, review by the study team, and compliance with applicable institutional and ethics requirements. Any additional participant consent required for the proposed use will be obtained before sharing. Names, contact details, and other direct identifiers will not be shared.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .